External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ASRS 2022
Roche and Genentech at

ASRS 2022

July 13 - July 16
New York, USA
asrs.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
03:30 PM
Duration 8mins Virtual
Key Surgical Pearls for the Prevention of Conjunctival Complications Following the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure
Wieland M, Callaway N, Menezes A, Singh N, Malhotra V
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:09 AM
Duration 6mins New York City
Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials
Khanani A, Demetriades AM, Kotecha A, Silverman D, Swaminathan B, Patel V, Lin H
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:16 AM
Duration 6mins New York City
Efficacy, Durability, and Safety of Faricimab in Diabetic Macular Edema: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Eichenbaum DA, Wells JA, Lim JI, Danzig C, Asik K, Haskova Z, Mohan S, Silverman D, Tang Y, Lin H
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:26 AM
Duration 6mins New York City
Exploring angiopoietin-2 (Ang-2) signaling in vascular stability patients with diabetic macular edema (DME) receiving faricimab in phase 2 and phase 3 trials
Csaky K, Modi Y, Sheth V, Haskova Z, Westenskow PD, Lin H
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:10 AM
Duration 6mins New York City
Central Subfield Thickness Fluctuations and Their Impact on Vision Outcomes Over 96 Weeks in the Archway Trial of the PDS
Sheth V, Blotner S, Heinrich D, Gune S, Chakravarthy U
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:31 AM
Duration 6mins New York City
End-of-Study Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab in Patients With nAMD
Rachitskaya A, Blotner S, Heinrich D, Gune S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:12 PM
Duration 4mins New York City
Long-term real-world treatment patterns among patients with diabetic macular edema initiating anti-VEGF: 6-year follow-up using the IRIS® Registry
Leng T, Garmo V, Tabano D, Kim E, Kuo B, Hatfield M, LaPrise A, Singh R
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:37 PM
Duration 6mins New York City
Personalized Treatment Interval (PTI) Dosing Dynamics Over 2 Years in the Phase 3 YOSEMITE and RHINE Trials of Faricimab in Diabetic Macular Edema
Kitchens JW, Baumal CR, Jaffe GJ, Gerendas BS, Abreu F, Camino A, Asik K, Jain N, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.